80 related articles for article (PubMed ID: 21228768)
1. Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease.
Verzola D; Procopio V; Sofia A; Villaggio B; Tarroni A; Bonanni A; Mannucci I; De Cian F; Gianetta E; Saffioti S; Garibotto G
Kidney Int; 2011 Apr; 79(7):773-82. PubMed ID: 21228768
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle myostatin mRNA expression is upregulated in aged human adults with excess adiposity but is not associated with insulin resistance and ageing.
Wilhelmsen A; Stephens FB; Bennett AJ; Karagounis LG; Jones SW; Tsintzas K
Geroscience; 2024 Apr; 46(2):2033-2049. PubMed ID: 37801203
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease.
Zhang L; Rajan V; Lin E; Hu Z; Han HQ; Zhou X; Song Y; Min H; Wang X; Du J; Mitch WE
FASEB J; 2011 May; 25(5):1653-63. PubMed ID: 21282204
[TBL] [Abstract][Full Text] [Related]
4. Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk.
Wu J; Dong J; Verzola D; Hruska K; Garibotto G; Hu Z; Mitch WE; Thomas SS
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1210-1227. PubMed ID: 31507080
[TBL] [Abstract][Full Text] [Related]
5. Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients.
Deger SM; Hung AM; Gamboa JL; Siew ED; Ellis CD; Booker C; Sha F; Li H; Bian A; Stewart TG; Zent R; Mitch WE; Abumrad NN; Ikizler TA
JCI Insight; 2017 Nov; 2(22):. PubMed ID: 29202452
[TBL] [Abstract][Full Text] [Related]
6. Adverse Effects of the Metabolic Acidosis of Chronic Kidney Disease.
Kraut JA; Madias NE
Adv Chronic Kidney Dis; 2017 Sep; 24(5):289-297. PubMed ID: 29031355
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of myostatin and its inhibition in the setting of chronic kidney disease.
Verzola D; Barisione C; Picciotto D; Garibotto G; Koppe L
Kidney Int; 2019 Mar; 95(3):506-517. PubMed ID: 30598193
[TBL] [Abstract][Full Text] [Related]
8. Association between Chronic Kidney Disease and Dynapenia in Elderly Koreans.
Lee DY; Shin S
Healthcare (Basel); 2023 Nov; 11(22):. PubMed ID: 37998468
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia in chronic kidney disease: from bench to bedside.
Kim DW; Song SH
Korean J Intern Med; 2023 May; 38(3):303-321. PubMed ID: 37077132
[TBL] [Abstract][Full Text] [Related]
10. Indoxyl sulfate mediates low handgrip strength and is predictive of high hospitalization rates in patients with end-stage renal disease.
Hou YC; Liu YM; Liao MT; Zheng CM; Lu CL; Liu WC; Hung KC; Lin SM; Lu KC
Front Med (Lausanne); 2023; 10():1023383. PubMed ID: 36817773
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acid and menaquinone-7 combination are helpful for aortic calcification prevention, reducing osteoclast area of bone and Fox0 expression of muscle in uremic rats.
Lee SM; Jeong EG; Jeong YI; Rha SH; Kim SE; An WS
Ren Fail; 2022 Dec; 44(1):1873-1885. PubMed ID: 36632744
[TBL] [Abstract][Full Text] [Related]
12. Muscle Wasting in Chronic Kidney Disease: Mechanism and Clinical Implications-A Narrative Review.
Cheng TC; Huang SH; Kao CL; Hsu PC
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682722
[TBL] [Abstract][Full Text] [Related]
13. Managing Musculoskeletal and Kidney Aging: A Call for Holistic Insights.
Cailleaux PE; Cohen-Solal M
Clin Interv Aging; 2022; 17():717-732. PubMed ID: 35548383
[TBL] [Abstract][Full Text] [Related]
14. Primary skeletal muscle cells from chronic kidney disease patients retain hallmarks of cachexia in vitro.
Baker LA; O'Sullivan TF; Robinson KA; Graham-Brown MPM; Major RW; Ashford RU; Smith AC; Philp A; Watson EL
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1238-1249. PubMed ID: 35029054
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological mechanisms leading to muscle loss in chronic kidney disease.
Wang XH; Mitch WE; Price SR
Nat Rev Nephrol; 2022 Mar; 18(3):138-152. PubMed ID: 34750550
[TBL] [Abstract][Full Text] [Related]
16. Myostatin/Appendicular Skeletal Muscle Mass (ASM) Ratio, Not Myostatin, Is Associated with Low Handgrip Strength in Community-Dwelling Older Women.
Choi SJ; Lee MS; Kang DH; Ko GJ; Lim HS; Yu BC; Park MY; Kim JK; Kim CH; Hwang SD; Kim JC; Won CW; An WS
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299795
[TBL] [Abstract][Full Text] [Related]
17. Formononetin ameliorates muscle atrophy by regulating myostatin-mediated PI3K/Akt/FoxO3a pathway and satellite cell function in chronic kidney disease.
Liu L; Hu R; You H; Li J; Liu Y; Li Q; Wu X; Huang J; Cai X; Wang M; Wei L
J Cell Mol Med; 2021 Feb; 25(3):1493-1506. PubMed ID: 33405354
[TBL] [Abstract][Full Text] [Related]
18. Muscle-Bone Crosstalk in Chronic Kidney Disease: The Potential Modulatory Effects of Exercise.
Leal DV; Ferreira A; Watson EL; Wilund KR; Viana JL
Calcif Tissue Int; 2021 Apr; 108(4):461-475. PubMed ID: 33388899
[TBL] [Abstract][Full Text] [Related]
19. Low Myostatin Serum Levels Are Associated with Poor Outcome in Critically Ill Patients.
Wirtz TH; Loosen SH; Buendgens L; Kurt B; Abu Jhaisha S; Hohlstein P; Brozat JF; Weiskirchen R; Luedde T; Tacke F; Trautwein C; Roderburg C; Koch A
Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32784522
[No Abstract] [Full Text] [Related]
20. Myostatin: The Missing Link between Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease?
Morioka T
J Atheroscler Thromb; 2020 Oct; 27(10):1036-1038. PubMed ID: 32435012
[No Abstract] [Full Text] [Related]
[Next] [New Search]
